Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8BBS

Structure of AKR1C3 in complex with a bile acid fused tetrazole inhibitor

Summary for 8BBS
Entry DOI10.2210/pdb8bbs/pdb
DescriptorAldo-keto reductase family 1 member C3, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, (4~{R})-4-[(1~{R},2~{S},5~{R},6~{R},13~{S},14~{S},17~{R},19~{R})-6,14-dimethyl-17-oxidanyl-7,8,9,10-tetrazapentacyclo[11.8.0.0^{2,6}.0^{7,11}.0^{14,19}]henicosa-8,10-dien-5-yl]pentanoic acid, ... (5 entities in total)
Functional Keywordsakr1c3, aldo-keto reductase, steroid metabolism, bile acid, tetrazole, cancer, oxidoreductase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight76931.90
Authors
Petri, E.T.,Skerlova, J.,Marinovic, M.,Brynda, J.,Kugler, M.,Skoric, D.,Bekic, S.,Celic, A.S.,Rezacova, P. (deposition date: 2022-10-14, release date: 2023-03-08, Last modification date: 2024-02-07)
Primary citationMarinovic, M.A.,Bekic, S.S.,Kugler, M.,Brynda, J.,Skerlova, J.,Skoric, D.D.,Rezacova, P.,Petri, E.T.,Celic, A.S.
X-ray structure of human aldo-keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis.
Rsc Med Chem, 14:341-355, 2023
Cited by
PubMed: 36846371
DOI: 10.1039/d2md00387b
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.4 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon